FDA approves Edwards' SAPIEN Valve, the first artificial aortic heart valve placed without open-heart surgery
advertisement
Systemic inflammation occurs in a substantial proportion of patients after transcatheter aortic valve replacement (TAVR), according to a paper published…
Among ‘real world’ patients with multivessel disease, percutaneous coronary intervention (PCI) improves survival compared with coronary artery bypass…
While cohort A of the PARTNER trial established transcatheter aortic valve replacement (TAVR) as noninferior to surgical AVR for high risk patients…
On the heels of the United States Food and Drug Administration’s (FDA) November 2011 approval of the first prosthetic device for use in transcatheter…
Drawing on 2 years’ worth of new data, an expert task force has published updated appropriate use criteria for revascularization. The new guidelines,…
Carotid endarterectomy (CEA) and carotid artery stenting (CAS) produce equivalent levels of restenosis out to 2 years following intervention, according…
Iodinated contrast media exposure is associated with development of hyperthyroidism as well as overt hypothyroidism, according to results from a study…
The presence of severe symptomatic aortic stenosis has little impact on rates of short term mortality and procedural complications in patients undergoing…
NEW YORK, NY—Data from a pair of small, preliminary studies suggest that stem cell therapy is safe and may improve long term cardiac function in patients…
Despite different baseline and anatomical characteristics, women with severe aortic stenosis show equivalent short term benefits from transcatheter…